Overview
Proof-of-concept Trial of Apraglutide in GVHD
Status:
Recruiting
Recruiting
Trial end date:
2025-08-30
2025-08-30
Target enrollment:
0
0
Participant gender:
All
All
Summary
The aim of this trial is to assess safety and efficacy of apraglutide in subjects with steroid refractory gastrointestinal acute graft versus host disease (aGVHD).Phase:
Phase 2Accepts Healthy Volunteers?
NoDetails
Lead Sponsor:
VectivBio AG
Criteria
Inclusion Criteria:- Able to give informed consent and agree to follow the details of participation as
outlined in the protocol
- Male or female subjects aged 12 years or above at the time of consent and who weigh a
minimum of 40 kg
- Histologically confirmed lower GI-aGVHD at screening (MAGIC stage 1-4) with clinically
confirmed SR
- Have undergone alloSCT from any donor source
- Treated with SS plus RUX at recommended dose twice daily for 0-5 days prior to
enrolment/randomization)
- Clinically confirmed SR GI-aGVHD
- Women of childbearing potential (WOCBP): highly effective method of contraception
during the trial and for 4 weeks after the End of Trial (EOT) visit
- Male subjects with partner WOCBP: contraception and abstention from sperm donation
during the trial and for 2 weeks after the EOT visit
Exclusion Criteria:
- Treatment with any systemic GVHD therapy other than SS and RUX: methotrexate &
mycophenolate mofetil at the time of enrolment/randomization
- Concomitant treatment with Janus kinase inhibitor other than RUX
- Systemic corticosteroid therapy for indications other than aGVHD within 7 days prior
to screening
- Failed previous alloSCT
- Any use of enteral glutamine or GLP analogs Significant organ system failures
(respiratory renal hepatic and cardiac)
- Relapsed primary malignancy GI tumors or colonic polyps
- Active clinically uncontrolled infection
- Known chronic GVHD
- Known active GI inflammation not related to GI-aGVHD
- Major abdominal surgery in the last 6-months prior to screening and history of
clinically significant intestinal adhesions
- Abnormal liver function tests